Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Lansoprazole on Kidney Volume and GFR in Thai ADPKD Patients
TCTR20210208005Phase 3Completed
- Sponsor
- Ramathibodi Hospital
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lansoprazole in autosomal dominant polycystic kidney disease (ADPKD), sponsored by Ramathibodi Hospital. Started Jan 2020; status: completed.
02
Drugs
lansoprazole
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)
Beyond the preview
Go deeper on TCTR20210208005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210208005.